Jul 30, 2026BoardMeeting
BoardPharmacy Benefits Managers Workgroup Meeting
The meeting focused on defining specialty drugs and specialty pharmacy operations. Key discussions included the role of specialty pharmacies in providing complex patient care, the lack of a universal definition for specialty drugs, and concerns regarding the potential abuse of specialty drug classifications by Pharmacy Benefits Managers (PBMs). Participants discussed the need for objective criteria to identify drugs requiring special handling versus those that could be safely managed by retail pharmacies. There was also a proposal to invite third-party experts to provide an analysis of the drug supply chain and pricing.